John Harrington

Plus aucun poste en cours

Fortune : 109 $ au 30/04/2024

56 ans

Consumer Services

Health Technology

Finance

Anciens postes connus de John Harrington

Sociétés	Poste	Début	Fin
ATHERSYS, INC.	Directeur/Membre du Conseil	24/10/1995	16/06/2022
	Directeur Technique/Scientifique/R&D	24/10/1995	16/06/2022
	Fondateur	24/10/1995	16/06/2022
BTHC VI, Inc.	Directeur Technique/Scientifique/R&D	-	06/09/2007
Athersys, Inc. /Old/ Athersys, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Athersys, Inc. manufactures & markets pharmaceutical products and is engaged in the development and commercialization of therapeutic products to treat significant and life-threatening diseases. The company has three primary focus areas, which include: regenerative medicine (applying the MultiStem, cell therapy platform), medicinal chemistry & pharmacology genomics. It was founded in December 1995 and is headquartered at Cleveland, OH.	Directeur/Membre du Conseil	08/06/2007	08/06/2007
	Directeur Technique/Scientifique/R&D	08/06/2007	08/06/2007
	Fondateur	08/06/2007	08/06/2007

University of California San Diego	Undergraduate Degree
Stanford University	Doctorate Degree

Internationale

Etats-Unis

Opérationnelle

Sectorielle

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
ATHERSYS, INC.	Health Technology

Entreprise privées	2
BTHC VI, Inc.	Finance
Athersys, Inc. /Old/ Athersys, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Athersys, Inc. manufactures & markets pharmaceutical products and is engaged in the development and commercialization of therapeutic products to treat significant and life-threatening diseases. The company has three primary focus areas, which include: regenerative medicine (applying the MultiStem, cell therapy platform), medicinal chemistry & pharmacology genomics. It was founded in December 1995 and is headquartered at Cleveland, OH.	Health Technology

Entreprise privées

BTHC VI, Inc.

Finance

Health Technology